DK0892796T3 - Isatinderivater som acetylcholinesteraseinhibitorer og analgetika - Google Patents

Isatinderivater som acetylcholinesteraseinhibitorer og analgetika

Info

Publication number
DK0892796T3
DK0892796T3 DK97908942T DK97908942T DK0892796T3 DK 0892796 T3 DK0892796 T3 DK 0892796T3 DK 97908942 T DK97908942 T DK 97908942T DK 97908942 T DK97908942 T DK 97908942T DK 0892796 T3 DK0892796 T3 DK 0892796T3
Authority
DK
Denmark
Prior art keywords
analgesics
acetylcholinesterase inhibitors
isatin derivatives
isatin
derivatives
Prior art date
Application number
DK97908942T
Other languages
Danish (da)
English (en)
Inventor
Stephen J Shimshock
Abdul E Mutlib
Susan M Chesson
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0892796T3 publication Critical patent/DK0892796T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK97908942T 1996-04-12 1997-03-07 Isatinderivater som acetylcholinesteraseinhibitorer og analgetika DK0892796T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63187096A 1996-04-12 1996-04-12
PCT/US1997/003598 WO1997038993A1 (en) 1996-04-12 1997-03-07 Isatin derivatives as acetylcholinesterase inhibitors and analgesics

Publications (1)

Publication Number Publication Date
DK0892796T3 true DK0892796T3 (da) 2001-11-19

Family

ID=24533114

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97908942T DK0892796T3 (da) 1996-04-12 1997-03-07 Isatinderivater som acetylcholinesteraseinhibitorer og analgetika

Country Status (19)

Country Link
EP (1) EP0892796B1 (no)
JP (1) JP4109718B2 (no)
KR (1) KR20000005379A (no)
CN (1) CN1215399A (no)
AR (1) AR006606A1 (no)
AT (1) ATE207483T1 (no)
BR (1) BR9708655A (no)
CA (1) CA2252039C (no)
DE (1) DE69707659T2 (no)
DK (1) DK0892796T3 (no)
ES (1) ES2165586T3 (no)
GR (1) GR3037006T3 (no)
HU (1) HUP9903473A3 (no)
IL (1) IL126308A0 (no)
NO (1) NO984740L (no)
PT (1) PT892796E (no)
TW (1) TW426678B (no)
WO (1) WO1997038993A1 (no)
ZA (1) ZA972990B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5523107B2 (ja) 2006-11-30 2014-06-18 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
US20110212928A1 (en) 2010-02-09 2011-09-01 The Johns Hopkins University Methods and compositions for improving cognitive function
AU2011216950A1 (en) 2010-02-16 2012-08-23 Pfizer Inc. (R)-4-((4-((4-(tetrahydrofuran-3-yloxy) benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
MX362886B (es) 2012-12-13 2019-02-22 H Lundbeck As Composición sinérgica que comprende vortioxetina y donepezilo para incrementar los niveles de acetilcolina en el cerebro, y el uso de la misma en el tratamiento de una disfunción cognitiva.
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
US10537552B2 (en) 2015-05-05 2020-01-21 Carafe Drug Innovation, Llc Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
AU2022380831A1 (en) * 2021-11-05 2024-06-06 Chinese University Of Hong Kong, Shenzhen Alpha-2a adrenergic receptor modulators and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994472A (en) * 1989-08-02 1991-02-19 Hoechst-Roussel Pharmaceuticals Incorporated 1-(pyridinylamino)-2-pyrrolidinones as pain relievers
US5296488A (en) * 1989-08-02 1994-03-22 Hoechst-Roussel Pharmaceuticals Inc. Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones

Also Published As

Publication number Publication date
JP4109718B2 (ja) 2008-07-02
JP2001508400A (ja) 2001-06-26
GR3037006T3 (en) 2002-01-31
IL126308A0 (en) 1999-05-09
CA2252039C (en) 2002-12-24
DE69707659T2 (de) 2002-05-08
ATE207483T1 (de) 2001-11-15
ZA972990B (en) 1997-11-03
AR006606A1 (es) 1999-09-08
AU2072597A (en) 1997-11-07
NO984740D0 (no) 1998-10-09
PT892796E (pt) 2002-03-28
CN1215399A (zh) 1999-04-28
DE69707659D1 (de) 2001-11-29
EP0892796B1 (en) 2001-10-24
TW426678B (en) 2001-03-21
KR20000005379A (en) 2000-01-25
HUP9903473A3 (en) 2000-09-28
AU716997B2 (en) 2000-03-16
ES2165586T3 (es) 2002-03-16
WO1997038993A1 (en) 1997-10-23
NO984740L (no) 1998-10-09
HUP9903473A2 (hu) 2000-05-28
EP0892796A1 (en) 1999-01-27
CA2252039A1 (en) 1997-10-23
BR9708655A (pt) 1999-08-03

Similar Documents

Publication Publication Date Title
NO984740D0 (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
NO955074D0 (no) 1-substituerte istain- og oksindolderivater som inhibitorer til acetylkolinesterase
ATE225784T1 (de) Indan- oder dihydroindolderivate
NO992725D0 (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO991922D0 (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
NO991676D0 (no) FremgangsmÕter og sammensetninger for immunmodulering
NO993217D0 (no) Br°nntetningssammensetninger og fremgangsmÕter
NO985977D0 (no) Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
DK0944590T3 (da) Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer
DK0900225T3 (da) Alkyl-4-silyl-phenoler og estere deraf som antiatherosklerosemidler
NO20005400D0 (no) Kinoloner anvendt som MRS-inhibitorer og baktericider
PT948483E (pt) Inibidores da farnesil-transferase
NO980718D0 (no) Bicykliske 4-aralkylaminopyrimidinderivater og tyrosinkinaseinhibitorer
FI955795A7 (fi) Aromaattisia asetyylikoliiniesteraasin inhibiittoreita
PT934280E (pt) Derivados 2-cianoiminoimidazolo inibidores da pde iv
FI953851L (fi) Silybidut asetyylikoliiniesteraase-inhibiittorit
NO985621D0 (no) FremgangsmÕte og system for boring under anvendelse av skum - skumsammensetning
FI960730L (fi) Indolijohdannaiset 5alfa-reduktaasi-1-inhibiittoreina
NO307727B1 (no) Fremgangsmåte og system for seriefeilvern
DK1042286T3 (da) Gamme-glutamyl- og beta-aspartyl-holdige immunmodulerende forbindelser og tilhørense fremgangsmåder
DE69720957T2 (de) Ace-hemmer
EE200000179A (et) 1-oxa, aza ja tianaftaleen-2-1 biseetrid fosfolambaani inhibiitoritena
SI0892796T1 (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics